Retatrutide

Retatrutide is a novel investigational peptide currently under study as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors. Receptor Targets: • GLP-1 (Glucagon-Like Peptide-1) receptor • GIP (Glucose-dependent Insulinotropic Polypeptide) receptor • Glucagon receptor Research Focus: • Metabolic regulation pathways • Energy balance and body weight management models • Insulin sensitivity investigations • Comparative activity to other GLP-1–based compounds Scientific interest continues to grow regarding its comparative activity to other GLP-1–based compounds in research models. For Research Use Only. Not intended for human consumption, cosmetic application, medical, diagnostic, or therapeutic purposes.